Yates, S. J., Weiss, J. J., Sneider, A., Geramita, E., Murthy, G. S. G., Badar, T., Im, A., Lin, C., Cheng, W., Abaza, Y., Swaroop, A., Winer, E. S., Litzow, M. R., Atallah, E. L., Patel, A. A. and Shallis, R. M. (2020) “Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2025.288085.